William Blair on Cullinan Oncology Inc. (CGEM): 'We continue to see multiple opportunities for upside to Cullinan shares'
William Blair analyst Matt Phipps reiterated an Outperform rating on Cullinan Oncology Inc. (NASDAQ: CGEM).The analyst comments "On Wednesday, June ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)